JP2010534646A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534646A5
JP2010534646A5 JP2010517535A JP2010517535A JP2010534646A5 JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5 JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5
Authority
JP
Japan
Prior art keywords
aza
bicyclo
hex
methyl
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010517535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534646A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/052985 external-priority patent/WO2009016560A2/en
Publication of JP2010534646A publication Critical patent/JP2010534646A/ja
Publication of JP2010534646A5 publication Critical patent/JP2010534646A5/ja
Pending legal-status Critical Current

Links

JP2010517535A 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体 Pending JP2010534646A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2007052987 2007-07-27
IB2008051167 2008-03-28
PCT/IB2008/052985 WO2009016560A2 (en) 2007-07-27 2008-07-25 Trans-3-aza-bicyclo[3.1.0]hexane derivatives

Publications (2)

Publication Number Publication Date
JP2010534646A JP2010534646A (ja) 2010-11-11
JP2010534646A5 true JP2010534646A5 (enExample) 2011-09-01

Family

ID=40130778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517535A Pending JP2010534646A (ja) 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体

Country Status (8)

Country Link
EP (1) EP2185512B1 (enExample)
JP (1) JP2010534646A (enExample)
CN (1) CN101790515A (enExample)
AT (1) ATE493386T1 (enExample)
CA (1) CA2693817A1 (enExample)
DE (1) DE602008004265D1 (enExample)
TW (1) TW200904799A (enExample)
WO (1) WO2009016560A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002809A1 (es) * 2006-09-29 2008-04-18 Actelion Pharmaceuticals Ltd Compuestos derivados de 3-aza biciclo [3.1.0]hexano; y su uso en el tratamiento de enfermedades tales como desordenes psicoticos y de ansiedad, desordenes del sueno, uso y abuso de sustancias psicoactivas, demencia y deterioro de funciones cognitivas
CA2687230A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
EP2275421A1 (en) 2009-07-15 2011-01-19 Rottapharm S.p.A. Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
CA2778949C (en) 2009-10-30 2018-02-27 Janssen Pharmaceutica Nv Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
EP2519519A4 (en) 2009-12-30 2013-04-24 Arqule Inc Substituted Naphthalenyl-pyrimidine compounds
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
JP5987005B2 (ja) 2011-02-18 2016-09-06 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン拮抗薬として有用な新規なピラゾール及びイミダゾール誘導体
JP6115962B2 (ja) 2011-06-27 2017-04-19 ヤンセン ファーマシューティカ エヌ.ベー. 1−アリール−4−メチル−[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体
US20140249024A1 (en) 2011-07-15 2014-09-04 Basf Se Pesticidal Methods Using Substituted 3-pyridyl Thiazole Compounds and Derivatives for Combating Animal Pests II
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
CN104220065A (zh) 2012-02-07 2014-12-17 Eolas治疗公司 取代的脯氨酸/哌啶用作食欲素受体拮抗剂
ITMI20120322A1 (it) 2012-03-01 2013-09-02 Rottapharm Spa Composti di 4,4-difluoro piperidina
PL2855453T3 (pl) 2012-06-04 2017-05-31 Actelion Pharmaceuticals Ltd. Pochodne benzimidazoloproliny
ES2855575T3 (es) 2012-06-26 2021-09-23 Janssen Pharmaceutica Nv Combinaciones que comprenden compuestos de 4-metil-[1,2,4]triazolo[4,3-a]quinoxalina como inhibidores de PDE2 e inhibidores de PDE10 para su uso en el tratamiento de trastornos neurológicos o metabólicos
MX362197B (es) 2012-07-09 2019-01-08 Janssen Pharmaceutica Nv Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos.
BR112015001201B1 (pt) * 2012-07-18 2022-02-22 University Of Notre Dame Du Lac Compostos anti-infecciosos 5,5-heteroaromáticos e composição
CN104703980B (zh) 2012-10-10 2017-09-22 埃科特莱茵药品有限公司 属于[邻双(杂)芳基]‑[2‑(间双(杂)芳基)吡咯烷‑1‑基]甲酮衍生物的食欲素受体拮抗剂
WO2014141065A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
LT3077389T (lt) 2013-12-03 2017-12-11 Idorsia Pharmaceuticals Ltd Kristalinė (s)-(2-(6-chlor-7-metil-1h-benzo[d]imidazol-2-il)-2-metilpirolidin-1-il)(5-metoksi-2-(2h-1,2,3-triazol-2-il)fenil)metanono forma ir jos panaudojimas kaip oreksino receptoriaus antagonisto
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
EP3077391B1 (en) 2013-12-04 2018-08-15 Idorsia Pharmaceuticals Ltd Use of benzimidazole-proline derivatives
US10221170B2 (en) 2014-08-13 2019-03-05 Eolas Therapeutics, Inc. Difluoropyrrolidines as orexin receptor modulators
SMT202200323T1 (it) 2016-02-12 2022-09-14 Astrazeneca Ab Piperidine alo-sostituite come modulatori del recettore di oressina
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
EP4196118A1 (en) 2020-08-13 2023-06-21 Boehringer Ingelheim International GmbH Treatment of cognitive impairement associated with schizophrenia
JP2023545808A (ja) 2020-10-13 2023-10-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 再加工方法
CN116783182B (zh) * 2021-02-02 2025-08-29 南京明德新药研发有限公司 四氢吡咯并环化合物及其应用
AR129309A1 (es) 2022-05-13 2024-08-07 Idorsia Pharmaceuticals Ltd Derivados de hidrazina-n-carboxamida cíclica sustituida con tiazoloaril-metilo
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130335D0 (en) * 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds
ATE344261T1 (de) * 2002-09-18 2006-11-15 Glaxo Group Ltd Cyclische n-aroylamine als orexinrezeptorantagonisten
CL2007002809A1 (es) * 2006-09-29 2008-04-18 Actelion Pharmaceuticals Ltd Compuestos derivados de 3-aza biciclo [3.1.0]hexano; y su uso en el tratamiento de enfermedades tales como desordenes psicoticos y de ansiedad, desordenes del sueno, uso y abuso de sustancias psicoactivas, demencia y deterioro de funciones cognitivas

Similar Documents

Publication Publication Date Title
JP2010534646A5 (enExample)
ES2350460T3 (es) Derivados de 3-aza-biciclo[3.1.0]hexano.
RU2010138640A (ru) Производные 2-аза-бицикло [2.2.1] гептана
CN101568536B (zh) 作为食欲素受体拮抗剂的2-氮杂-双环[3.1.0]己烷衍生物
US8063099B2 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
EP2185512B1 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
JP2010534647A5 (enExample)
JP5934403B2 (ja) 5,6−ジヒドロ−1h−ピリジン−2−オン化合物
JP2010536740A5 (enExample)
JP2010514751A5 (enExample)
JP2007519694A5 (enExample)
JP2010504957A5 (enExample)
KR20160142334A (ko) 시클로프로판아민 화합물 및 이의 용도
CA2729985A1 (en) Thiazolidine compounds as orexin receptor antagonists
CN101501039A (zh) 吡咯并[1,2-b]哒嗪酮化合物
CN108463461A (zh) 头孢烯化合物、其制备和用途
RU2010103322A (ru) Соединения 3-аза-бицикло[3.3.0]октана
IL307868A (en) Compounds for use in the treatment of hyperproliferative disorders
HK1136554B (en) 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
HK1201822B (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds